PerkinElmer and Novartis Collaborate to Address the Unmet Need of Sickle Cell Disease in Sub-Saharan Africa
PerkinElmer’s contributions to the Novartis Africa Sickle Cell Disease program will accelerate access to sickle cell disease screening and treatment across the continent WALTHAM, Mass. – June 16, 2022 – PerkinElmer Inc., a global leader committed to innovating for a healthier world, today announced that it is collaborating with Novartis, a leading global medicines company,... Read more